Molecular therapy for Miscarriage: Lin-28, the RNA binding protein, may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015, 22.26

Molecular therapy for Miscarriage: Lin-28, the RNA binding protein, may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015, 22.26

Molecular therapy for Miscarriage: Lin-28, the RNA binding protein, may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015, 22.26 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, that Lin-28, by decreasing the expression of its target gene, it may inhibit early pregnancy loss, while promoting fetal growth. Thus, pharmacological formulations encompassing “Lin-28 activators” may be used to protect pregnant women from miscarriage, while promoting fetal growth. 

Citation: Boominathan, Molecular therapy for Miscarriage: Lin-28, the RNA binding protein,  may inhibit early pregnancy loss and promote fetal growth via down regulation of its target gene, 23/March/2015,  22.26, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Lin-28 inhibits early pregnancy loss and promotes fetal growth

* Research cooperation

Share
Start Typing